Scientists Cure Color Blindness In Monkeys Sep 17, 2009
D., a professor of ophthalmic molecular genetics at the UF College of Medicine and a member of the UF Genetics Institute and the Powell Gene Therapy Center. "Although color blindness is only moderately life-altering, we've shown we can cure a cone disease in a primate, and that it can be done very safely. That's extremely encouraging for the development of therapies for human cone diseases that really are blinding.". (Science Daily)
Pieris AG Enters into Anticalin Collaboration With Allergan, Inc. Sep 15, 2009
FREISING-WEIHENSTEPHAN, Germany, September 15 /PRNewswire/ -- Pieris AG today announced that they have entered into a collaboration agreement with Allergan, Inc. (NYSE: ) that combines Pieris' proprietary Anticalin technology with Allergan's expertise in drug delivery and ophthalmic drug development with a goal of developing agents for the treatment of serious ocular disorders. Under the terms of the collaboration Pieris will work with Allergan to optimize existing lead Anticalins and to design... (PR Newswire)
Flying hospital Sep 12, 2009
With a fully equipped plane, donated by United Airlines, doctors trained in the latest ophthalmic techniques could bring their surgical knowledge and skills to the doctors and patients in developing countries. The local doctors can then use their newly learned skills in their homeland. (BBC News -- Africa)
Life sciences company raises $5M investment Sep 9, 2009
Over time, all diabetics are at risk of developing DME. There are no ophthalmic drug therapies approved by the FDA for the treatment of this disease. Each Iluvien insert is designed to provide a sustained therapeutic effect of up to 36 months, for the low dose of Iluvien, and up to 24 months, for the high dose of Iluvien, according to a statement. (Atlanta Business Chronicle, GA)
ISTA Pharmaceuticals Announces Preliminary Results of T-Pred Studies Sep 9, 2009
Sept. 8 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ), today announced preliminary results from two recently completed studies on its investigational ophthalmic product, T-Pred(TM) (prednisolone acetate 1 ... 3% ophthalmic suspension) ... ISTA Pharmaceuticals is the fourth largest branded ophthalmic pharmaceutical business in the U.S. ISTA's three marketed products plus its product candidates include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. (PR Newswire)
ISTA Pharmaceuticals' Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies Sep 9, 2009
Sept. 8 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ) today announced the U.S. Food and Drug Administration (FDA) has approved Bepreve(TM) (bepotastine besilate ophthalmic solution) 1 ... About Bepreve(TM) (bepotastine besilate ophthalmic solution) 1 ... In 2001, Tanabe Seiyaku granted Senju Pharmaceutical Co., Ltd., exclusive worldwide rights, with the exception of certain Asian countries, to develop, manufacture and market bepotastine for ophthalmic use. (PR Newswire)
United States Patent and Trademark Office Publishes Stemedica's Patent Application for the Treatment of Diabetic Retinopathy Sep 8, 2009
Annual physical and ophthalmic examinations were conducted each year thereafter for a three year period. Noticeable patient findings included: overall visual function improvements by all eight patients within sixty (60) days of treatment; reduction in absolute scotomas; increases in the thickness of the optic nerve fiber; resorption of hemorrhages; no new micro bleeding edema of the nerve fiber layer; and, a decrease in macular edema. (PR Newswire)
Teen who cries blood gets help from experts Sep 5, 2009
Haik and a team of researchers published a 2004 study in the Journal of the American Society of Ophthalmic Plastic and Reconstructive Surgery looking specifically at children who developed unexplained, spontaneous episodes of bloody tears between February 1992 and January 2003. Only four cases were recorded. (CNN)
Abbott buys vision care unit for $400M Sep 3, 2009
Visiogen, which has 65 employees, creates ophthalmic medical devices. Its primary product is a lens implant designed to improve vision in cataract patients. (Crain's Chicago Business)
Gene signal GS-101 data shows safe and effective inhibition of ophthalmic blood vessel growth Sep 1, 2009
"The publication of these positive phase II results for GS-101 is a major milestone for Gene Signal. As a novel approach to the management of ophthalmic angiogenesis, we are keen to provide rigorous scientific backup to support our ongoing clinical development program. We also recently published data in the Journal of Pharmacology and Experimental Therapeutics confirming that GS-101 prevents in vivo expression of IRS-1, a protein associated with new blood vessel formation (angiogenesis), and we... (EurekAlert!)
Safety, efficacy of corneal transplant procedure confirmed; an antibiotic can cause double vision Sep 1, 2009
Descemet's Stripping Endothelial Keratoplasty (DSEK) corneal transplant procedure is a safe and effective treatment for corneal endothelial diseases, says a 2009 review by the cornea panel of the Academy's Ophthalmic Technology Assessment Committee, led by W. Barry Lee, M.D. The panel reached this conclusion through a comprehensive review of pertinent studies published from 1980 to 2009 ... He also said that special care should be taken with patients who are older than 60, have had renal... (EurekAlert!)
Shingles Complications and Treatmen... Aug 23, 2009
According to a 2000 article in Opthamology Times by Lynda Charters and Alan Palestine entitled Famcyclovir an option for ophthalmic zoster," Famcyclovir may reduce symptoms of herpes zoster opthalmicus, particularly if started early in the progression of the infection. This article indicates that famcyclovir is more effective than acyclovir in treating herpes zoster opthalmicus. Bacterial Infection Resulting From a Shingles Infection According to the CDC, a superinfection of bacteria may occur... (Suite101.com)
Mind Control Can Make You A Better Surgeon Aug 21, 2009
Published in BMC Neuroscience 2009 this month, the study, led by Tomas Ros and Professor John Gruzelier, both from Goldsmiths, University of London, specifically looked at the effects of self-regulating brainwaves on National Health Service trainee ophthalmic microsurgeons. Neurofeedback is a kind of brain training which involves brain activity being monitored by sensors, so that individuals can see the activity on a screen. (Science Daily)
Inspire Pharmaceuticals is in a whirlwind of change Aug 18, 2009
DURHAM -- Inspire Pharmaceuticals, a drug company focusing on ophthalmic and pulmonary diseases in southern Durham, has gone through a spate of changes this month. . (Herald Sun)
Physicians join eye office Aug 16, 2009
James Kirszrot, MD specializes in Ophthalmic Plastic, Reconstruction and Cosmetic Eyelid Surgery. Roberto Cavalieros, MD specializes in General Ophthalmology and Cataract Surgery, including Premium Intraocular Lenses. (Lexington Minuteman, MA)
Health costs Aug 16, 2009
Health care free at point of delivery but charges for prescription drugs, ophthalmic services and dental services unless exempt. Exemptions include children, elderly, and unemployed. (BBC News -- Health)
Blood donors on tap at floating hospital Aug 5, 2009
The "Africa Mercy," currently docked off the coast of Benin, West Africa, also operates as a floating hospital with medical facilities including six state-of-the-art operating theaters, an ophthalmic unit, two CT scanners and 78 hospital beds onboard. The charity began in 1978 and since then has been credited with providing medical services valued at $748 million, performing more than 41,000 operations and impacting approximately two million people. (CNN -- Health)
F1: Massa leaves hospital in Brazil after tests Aug 5, 2009
"We did new blood exams, repeated brain tomography, brain resonance, he's undergone a ophthalmic exam, and the conclusion is that Felipe has no need of a new surgery right now," physician Dino Altman said. "The only recommendation for him is for rest at home.". (India Times, India)
Tiny Telescopes Help the Blind See Again Jul 21, 2009
Better still, for squeamish emergency room pansies like myself, this is a "brief" outpatient procedure, say the inventors at VisionCare Ophthalmic Technologies. Just pop a telescope in your bad eye and you'll be avoiding home furniture by the evening. (Newsmax)
New Evidence That Popular Dietary Supplement May Help Prevent, Treat Cataracts Jul 21, 2009
23, 2004) The Food and Drug Administration (FDA) has announced the approval of Vision Blue (trypan blue ophthalmic solution). Vision Blue is the first product approved in the United States for staining the. (Science Daily)
Lumenis' UltraPulse TotalFX Treatment Featured on ABCNews 20/20 as a Secret Weapon for Treating for Burn Scars Jul 20, 2009
Lumenis Ltd., the world's leading medical laser company is a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic and ophthalmic applications, with more than 800 employees globally. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems. (PR Newswire)
Ultraviolet Protection of the Eyes Jul 8, 2009
Checking the UV protection factor of sunglasses helps prevent painful and debilitating ophthalmic conditions. It is not necessary to buy expensive sunglasses as even some of the cheapest generic, non-branded models provide excellent protection while also being stylish and fashionable. (Suite101.com)
Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis Jul 6, 2009
"This is the first step in the ophthalmic clinical development program for NVC-422, which has the immediate goal of developing the first effective product to address viral conjunctivitis for which there are limited treatment options." ... Alcon, which has been dedicated to the ophthalmic industry for more than 65 years, researches, develops, manufactures and markets pharmaceutical products, surgical equipment and devices, contact lens care solutions and other vision care products that treat... (PR Newswire)
Dog-eaten passport cancels Wis. boy's trip to Peru Jun 30, 2009
STAAR Surgical Company (Nasdaq: STAA), a developer, manufacturer and marketer of implantable lenses and related ophthalmic products, today announced the unanimous appointment of Richard (Randy) A. Meier (49), the former president and chief operating officer of Advanced Medical Optics (AMO), to the Company's board of directors ... Mr. Meier was the former president and chief operating officer of AMO, a global leader in ophthalmic products including intraocular lenses (IOLs) and laser vision... (Fresno Bee)
'Nature' and 'nurture' variables early predictors of AMD Jun 26, 2009
"The determinants of the model can be assessed by completing a questionnaire and taking a blood test, and it is a tool which could be used to help guide prevention and treatments" said lead author and principal investigator, Johanna M. Seddon, MD, ScM, Professor of Ophthalmology at Tufts University School of Medicine and Director of the Ophthalmic Epidemiology and Genetics Service at Tufts Medical Center. "Such information may be also be useful for screening those at high risk of AMD due to a... (EurekAlert!)
Transcend Medical raises $35M in 2nd round Jun 23, 2009
an ophthalmic device company focused on the treatment of glaucoma, said Monday it raised $35 million in a second round of funding. Menlo Park-based Transcend said the lead investor was , which has an office in San Francisco. (San Jose Business Journal, CA)
I-Therapeutix, Inc. Closes $15 Million Financing Jun 20, 2009
The proceeds will be used to commercialize I-ZIP(R) Ocular Bandage in the United States and to develop sustained drug delivery products for treatment of ophthalmic diseases and ocular infections ... "In a financing environment that has been challenging for MedTech companies, we welcome the new vote of confidence by Polaris Venture Partners. We look forward to working with our investors to continue building a solid ophthalmic company," commented I-Therapeutix President and CEO, Amar Sawhney ...... (PR Newswire)
New supplement may help slow sight loss in elderly Jun 19, 2009
Professor Chakravarthy, who is also a Consultant Ophthalmic Surgeon at the Royal Hospital in Belfast, said: "Late AMD causes severe sight loss and has a huge economic impact both in terms of the effects of sight loss itself and in terms of the expensive treatments that are needed to deal with the condition. "Up to 500 people a year in Northern Ireland will lose sight in one or both eyes as a result of late AMD.. "We wanted to carry out the study as prevention of progression to late AMD can... (EurekAlert!)
CCMH board approves surgery equipment purchase Jun 19, 2009
Published: Thursday, June 18, 2009 9:42 AM CDT At their monthly meeting Wednesday morning, members of the Cass County Memorial Hospital Board of Trustees approved the purchase of a Surgical Microscope for the Ophthalmic Surgery to replace an old piece of equipment at the facility. ADVERTISEMENT. (Atlantic News-Telegraph, IO)
Opko acquires rights to new technology Jun 18, 2009
Opko, which is developing drugs for ophthalmic disease, will initially use the technology to develop blood tests for several diseases that are not available and for which early diagnosis is difficult, Chairman and CEO Dr. Phillip Frost said in a press release. We plan to begin with tests for Alzheimer s disease, multiple sclerosis, Parkinson s disease and lung cancer, said Frost, who is one of South Florida's most prominent entrepreneurs with a net worth estimated at $1. (South Florida Business Journal, FL)
OptiMedica Selects Glassbeam to Gain Insight Into Product Operational Data Jun 17, 2009
Sunnyvale, CA (PRWEB) June 17, 2009 -- Glassbeam announced today that global ophthalmic company OptiMedica has selected Glassbeam for mining its operational data ... We are excited to be working with a thought leader and a fast growing company like OptiMedica in helping them understand their products and scale to meet their growth," said Puneet Pandit, CEO of Glassbeam. The is applicable to companies across multiple verticals such as software, servers, storage, networking, telecom, medical... (Yahoo News -- Press Releases)
Opko invests in Cocrystal Discovery Jun 16, 2009
On June 11, Opko (AMEX: OPK), which is developing drugs for ophthalmic disease, said it was investing$2. 3 million in Sorrento Therapeutics, a San Diego-based biotechnology firm. (South Florida Business Journal, FL)
Synergetics profit down Jun 16, 2009
-based Synergetics USA Inc. (Nasdaq: SURG) manufactures and designs medical devices for use in ophthalmic surgery and neurosurgery. Reader Comments. (St. Louis Business Journal, MO)
Beating Bacteria to Prevent Post-LASIK Infections Jun 6, 2009
ScienceDaily (June 5, 2009) Since bacteria mutate frequently and become resistant to new antibiotics, ophthalmic researchers are on a continuous quest to identify the worst offenders and best treatments ... "Since resistant CNS is now widespread, it makes sense to develop ophthalmic agents using the newest fluroquinolones and to consider their use after refractive surgery to attempt to reduce infections, " Dr. Seo said. (Science Daily)
Miracle Treatment for Burn Scars as Seen on Today Show Will Also Be Featured on The Insider Tonight May 29, 2009
a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, is Israel's largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. (PR Newswire)
FDA extends review for Centocor drug May 28, 2009
The FDA s dermatologic and ophthalmic drugs advisory committee unanimously recommended Stelara for approval in June 2008. Centocor Ortho Biotech is a wholly owned subsidiary of Johnson & Johnson (NYSE:JNJ) of New Brunswick, N.J.. (Philadelphia Business Journal, PA)
FDA Extends Review Timeline for STELARA(TM) (ustekinumab) Biologic License Application by Three Months May 27, 2009
The FDA's Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) unanimously recommended STELARA for approval in June 2008. In December 2008, Centocor Ortho Biotech announced the receipt of a Complete Response letter for STELARA from the FDA requesting additional information, including a proposal for a Risk Evaluation and Mitigation Strategy (REMS), to which Centocor Ortho Biotech responded in January 2009. (PR Newswire)
Drug For Urination Difficulties Linked With Complications After Cataract Surgery May 26, 2009
ScienceDaily (May 26, 2009) Use of the medication tamsulosin to treat male urination difficulties within two weeks of cataract surgery is associated with an increased risk of serious postoperative ophthalmic adverse events such as retinal detachment or lost lens, according to a new study ... "Cataract surgery is the most commonly performed operation in the United States today. With nearly 2 million cataract operations performed in the United States each year, the magnitude of IFIS associated... (Science Daily)
Headaches explained as 'hypnic' May 20, 2009
I was diagnosed with ophthalmic migraines and found that as soon as I felt the symptoms come on, I had to sit or lie down for about 15 minutes with my eyes closed to stop the blackness and minimize the headache ... A Ophthalmic or ocular migraines don't cause a headache. (Erie Times-News, PA)
College grads facing unemployment, uncertainty May 13, 2009
She also founded the Center for Ophthalmic Innovation at the Bascom Palmer Eye Institute, which is funded by the Department of Defense. A graduate of Dedham High School, Fini has taught at Tufts and Harvard schools of medicine, among others. (Easton Journal, MA)
Opko Health narrows Q1 net loss May 9, 2009
The company also disclosed in the filing that it leased a 10,000-square-foot facility in Hialeah to house its ophthalmic instrumentation manufacturing and service operations. It signed a one-year lease for $110,000. (South Florida Business Journal, FL)
Isotechnika announces a strategic collaboration and financing with Paladin Labs May 7, 2009
In addition to the uveitis trials, Lux BioSciences Inc. has also commenced a Phase 1 trial using their proprietary voclosporin ophthalmic solution (LX214) as a candidate for dry eye syndrome. Voclosporin has also entered First-in-Man trials as the drug utilized in the CINATRA(TM) Drug Coated Coronary Stent system developed by the Company's partner, Atrium Medical Corporation. (Canada Newswire)
National Coalition for Capital & Florida Partners Applaud the Florida Legislature for Passing Fast Track Economic Stimulus Legislation May 1, 2009
"Enterprise Florida has sponsored a federally-approved Community Development Entity that has assembled a list of projects, such as the expansion/renovation of Florida Nexus Park in Fort Pierce, which will create about 500 jobs in Manufacturing, R&D and sales and support services for Ophthalmic and emerging bio-science related operations. These projects will be feasible with the addition of financing made possible with New Markets Tax Credits.". According to a recent poll conducted by McLaughlin... (PR Newswire)
Shobhaa De: No Englis, pliz Apr 19, 2009
Professional qualifications become disqualifications an Ophthalmic doctor from Mumbai has been rubbished as a socialite since she lives in a posh locality. Ditto for the banker who wears pearls. (India Times, India)
Asian Stocks Climb as Fed's Beige Book Fuels Growth Optimism; Tenaga Rises Apr 16, 2009
a Japanese maker of ophthalmic drugs, surged 11 percent after licensing sales rights for its glaucoma medication to. Futures on the Standard & Poors 500 Index lost 0. (Bloomberg -- Asia)
Asahi Glass, Aderans, Doutor, NEC Electronics, Takashimaya: Japan Stocks Apr 16, 2009
The ophthalmic medicine maker said it has signed a license agreement with (MRK US) on tafluprost, a treatment for glaucoma, allowing the U.S. drugmaker to sell the drug in the Americas, Africa and western Europe excluding Germany. (8233 JT) rallied 5 percent to 700 yen. (Bloomberg -- Japan)
Viagra may blur vision only for a while Apr 14, 2009
The men underwent comprehensive ophthalmic tests, including electro-retinography (test to measure the electrical response of the light-sensitive rods and cones in the eye, used to detect diseases of the retina) before, during and after treatment. Among the 194 men (79. (India Times, India)
Transplanting hope Apr 10, 2009
The sclera, or the white part of the eye, can also be used, ophthalmic assistant at Northern Montana Hospital Diane Forsyth said in a press release from the hospital. The sclera is mainly used for reconstructive surgeries, Knight said. (Havre Daily News, MT)
Unraveling psoriasisatthe genetic level Apr 3, 2009
The new drug, ustekinumab, was recently approved for use in Europe and Canada and was unanimously recommended for approval in the U.S by the FDAs Dermatologic and Ophthalmic Drugs Advisory Committee last June. In December, however, the FDA requested additional information from the drugs maker, Centocor, including a Risk Evaluation and Mitigation Strategy, which would include a medication guide and communication plan. (MSNBC -- Health)
Ophthalmic loss widens to $2.5M Apr 2, 2009
Ophthalmic loss widens to $2 ... Ophthalmic loss widens to $2 ... Ophthalmic s fourth-quarter revenue dropped to $3 million, from $3. (Sacramento Business Journal, CA)
FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration Apr 1, 2009
March 30 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for individuals with age-related macular degeneration (AMD), today announced the FDA Ophthalmic Devices Advisory Panel unanimously recommended that the FDA approve, with conditions, the premarket application (PMA) for its implantable telescope for End-Stage AMD. The implantable telescope is the first medical device to be recommended by the panel for FDA approval for End-Stage AMD,... (PR Newswire)
Ellensburg eye doctor impacted many lives Mar 27, 2009
Lucy Picari, an optician and ophthalmic assistant at the Boys Smith clinic, said she has known Boys Smith since she was a young woman when he was practicing and teaching in Columbia ... Keith Hartley, who worked in the local clinic from 1992 through 2002 as an ophthalmic technician, said Boys Smith was a compassionate caregiver and was continuously teaching, mentoring and encouraging his employees ... (He) and his dear wife, Alicia, noticed the interest and care that I had for the patients and... (Ellensburg Daily Record, WA)
Endure Medical Redefines Ophthalmic Surgical Microscopes Mar 20, 2009
(PRWEB) March 20, 2009 -- Endure Medical () has created a ophthalmic surgical microscope that delivers the best of all worlds ... Finally, ophthalmic surgeons have an American Made option that delivers. (Yahoo News -- Press Releases)
Unique nerve-stimulation device proves effective against epilepsy Mar 19, 2009
"The major branches of the trigeminal nerve in the face are located close to the surface of the skull; that allows physicians to assess response prior to permanent implantation of a future device. "For all of these reasons, we need to find non-drug and non-surgical alternatives," he said. "The results of our study are very encouraging and support further investigation into the safety and efficacy of TNS." ### DeGiorgio and his colleagues are currently recruiting 50 patients, age 18 and older,... (EurekAlert!)
Synergetics moves to profit Mar 17, 2009
Domestic ophthalmic sales decreased 2. 5 percent, while international ophthalmic sales increased by 31 ... -based Synergetics USA Inc. (Nasdaq: SURG) manufactures and designs medical devices for use in ophthalmic surgery and neurosurgery. (St. Louis Business Journal, MO)
Singapore, UK Researchers Discuss New Ways to Fight Microbes, Prevent Vision Loss Mar 16, 2009
The Singapore Eye Research Institute (SERI) is the main research institute for ophthalmic and vision research in Singapore. As the research institute of the Singapore National Eye Centre, SERI is directly affiliated to the National University of Singapore, and Duke-NUS Graduate Medical School, and collaborates with the foremost institutions worldwide. (JCN Network, Japan)
DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology Mar 12, 2009
The license DSM obtained applies for the development of drug delivery systems aimed at treating ophthalmic, (cardio)vascular, musculoskeletal diseases and at providing general pain relief. MediVas will focus its development efforts on nanoparticle based therapies in oncology, immunology and on the delivery of nucleic acids. (PR Newswire)
Lumenis(R) Introduces Cost-Saving Innovations at the 2009 American Academy of Dermatology (AAD) Annual Meeting Mar 11, 2009
March 10 /PRNewswire/ -- Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radio-frequency devices for surgical, aesthetic, and ophthalmic applications, unveiled two new laser innovations at the American Academy of Dermatology (AAD) annual meeting in San Francisco, California which specifically address economic challenges facing the cosmetic industry. The LightSheer(R) Duet(TM) Diode Laser System and the UltraPulse 4X CO2 Laser System offer significant... (PR Newswire)
Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction Mar 5, 2009
March 5 /PRNewswire/ -- Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radio-frequency devices for surgical, aesthetic, and ophthalmic applications, announced today plans to launch the LightSheer(R) Duet(TM) Diode Laser System for high-speed permanent hair reduction at the American Academy of Dermatology annual meeting in San Francisco this weekend. "The LightSheer Duet is the most exciting innovation in laser hair removal since LightSheer first... (PR Newswire)
Bausch & Lomb, Santen Strike Licensing Agreement for IOL Development Mar 3, 2009
Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Bausch & Lomb is one of the best-known and most respected healthcare brands in the world. (PR Newswire)
Rick Fraunfelder, M.D. of the Casey Vision Correction Center in Portland, Oregon, Joins Elite Group of Surgeons Listed at Trusted LASIK Surgeons Feb 26, 2009
The most significant professional qualifications that set Dr. Rick Fraunfelder apart from nearly all other LASIK Surgeons are his experience as a principal investigator for an FDA study for Nidek and member of the FDA Ophthalmic Devices panel study, his academic appointment at Casey Eye Institute, and his extensive research ... "We are honored to have Dr. Fraunfelder join our Trusted Lasik Directory. The Casey Eye Institute has a long history of contributions to the field of refractive surgery... (Yahoo News -- Press Releases)
Stimulus Package and Its Impact On EHR and Abraxas Feb 25, 2009
0, is a CCHIT Certified(r) 2006 Ambulatory EHR. Abraxas is a wholly-owned subsidiary of Ophthalmic Imaging Systems (OIS). Contact. (Primezone Releases)
Escalon(R) Reports Second Quarter Fiscal 2009 Results Feb 18, 2009
Founded in 1987, the Company () develops markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. Drew Scientific, which operates as a separate business unit, provides instrumentation and consumables for the diagnosis and monitoring of medical disorders in the areas of diabetes, cardiovascular diseases and hematology, as well as veterinary hematology and blood chemistry. (PR Newswire)
Chattanooga: Regional bankruptcies climb 25% Feb 16, 2009
Mrs. Reed, an ophthalmic laboratory technician, filed for Chapter 13 bankruptcy in 2004 to avoid having the family home foreclosed upon after her husband died and the family was unable to keep up the house payments. Mr. Reed, a self-employed auto mechanic, said that in 2001 he obtained a $76,000 loan from Option One Mortgage Corp. to renovate the 103-year-old house. (Chattanooga Times Free Press)
True love looks under the skin Feb 14, 2009
An ophthalmic plastic surgeon, Aaron Fay, worked on her eyes. Doctors Mack Cheney and Tessa Hadlock of the Facial Plastic and Reconstructive Surgery Center rebuilt her nose from a rib covered with skin from her forehead. (Boston Globe)
